Hilton Hotels Corporation Common Stock vs Eli Lilly And Co — how do they compare? Hilton Hotels Corporation Common Stock trades at $318 (market cap $70.82B), while Eli Lilly And Co trades at $1,211 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 15.2× Hilton Hotels Corporation Common Stock's market cap, and Eli Lilly And Co pays the higher dividend (0.57%). Which is the better fit depends on your goals.
| HLT | LLY | |
|---|---|---|
Market Cap | $70.82B | $1.08T |
Sector | Consumer Cyclical | Health |
52-Week High | $350.22 | $1.24K |
52-Week Low | $256.75 | $639.43 |
Enterprise Value | $83.83B | $1.13T |
Dividend Yield | 0.19% | 0.57% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,231.58, up 3.87% in the past 24 hours, reflecting strong momentum near its 52-week high. The stock exhibits bullish technical signals with robust fundamentals, including 48% revenue growth in Q2 2026 and a net income margin of 33.53%. Recent news highlights legal actions against black-market drug sales and positive analyst sentiment following earnings beats.
Outlook remains positive with a consensus price target of $1,380, though high valuation ratios (P/E 40.79) and regulatory risks pose challenges. Earnings growth and pipeline advancements, like retatrutide, drive upside potential, but investors should monitor competitive pressures and execution risks.
Trailing returns across standard periods
Latest headlines on both assets
Hilton Worldwide Holdings operates 1,074,791 rooms across its 18 brands addressing the midscale through luxury segments as of Dec. 31, 2021. Hampton and Hilton are the two largest brands by total room count at 28% and 21%, respectively, as of Dec. 31, 2021. Recent brands launched over the last few years include Home2, Curio, Canopy, Tru, and Tempo. Managed and franchised represent the vast majority of adjusted EBITDA, predominantly from the Americas regions.
Read more on HLT →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →